• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Identification of a genetic susceptibility locus in patients with severe Covid-19

byThomas SuandDeepti Shroff Karhade
June 27, 2020
in Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A 6-gene cluster at the locus 3p21.31 was determined to be related to Covid-19 susceptibility.

2. The ABO blood-group system was associated with disease severity, with group A facing higher risk and group O benefitting from a protective effect.

Evidence Rating Level: 3 (Average)

Study Rundown: Given the murky pathogenesis of Covid-19 and the variability in its manifestations, identification of potential genetic factors may guide clinical risk profiling and improve overall understanding of the disease’s underlying pathophysiology. This study, which involved patients with Covid-19-induced respiratory failure from Italy and Spain, detected 2 independent cross-replicating associations that were significant at the genomewide level. At locus 3p21.31, composed of 6 genes, the rs11385942 indel GA variant was most strongly associated with increased risk. The associated signal of locus 9q34.2 coincided with the ABO blood group locus. Twenty-four additional associations that exceeded the suggestive significance threshold were noted. While these findings were consistent with those of the global Covid-19 Host Genetics Consortium, this study had some limitations. Because this study was conducted at the peak of the pandemic in early 2020, minimal patient data was collected, which precluded adjustment for potential confounds such as comorbidity. Further, participants of non-European ancestry were excluded from analysis, which limited the generalizability of the results. Nonetheless, these findings indicate a genetic element to Covid-19, and further research should be done to elucidate the functional consequences of these associations.

Click here read the study in NEJM

Relevant Reading: An updated review of the association of host genetic factors with susceptibility and resistance to COVID‐19

In-Depth [case-control study]: The study population consisted of 1610 patients with Covid-19 who were hospitalized with respiratory failure in various epicenters of Italy and Spain from early April to early June of 2020. Genomic data from these patients were compared to data from 2205 control participants, with the thresholds for significant association and suggestive association being defined as 5 x 10-8 and 1 x 10-5, respectively. At locus 3p21.31, which encompassed genes SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, and XCR1, the odds ratio (OR) for the lead variant GA allele was 1.77 (95% confidence interval [CI], 1.48 to 2.11; P=1.15 x 10-10). The frequency of this allele was also higher among patients who required mechanical ventilation versus those who received only supplemental oxygen (adjusted OR, 1.56; 95% CI, 1.17 to 2.01; P=0.003). At locus 9q34.2, the odds ratio for the lead variant A allele was 1.32 (95% CI, 1.20 to 1.47; P=4.95 x 10-8). Persons with blood group A faced greater risk of respiratory failure compared to those with non-A blood groups (OR, 1.45; 95% CI, 1.20 to 1.75; P=1.48 x 10-4), while persons with blood group O faced lower risk compared to those with non-O blood groups (OR, 0.65; 95% CI, 0.53 to 0.79; P=1.06 x 10-5). The human leukocyte antigen (HLA) loci were also investigated due to their involvement in several viral infections, but no association signals were detected in those regions.

RELATED REPORTS

Unvaccinated status increases risk of long COVID symptoms

The 2 Minute Medicine Podcast Episode 6

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood typeCoronavirusgenomicsSARS-CoV-2
Previous Post

Lincocin associated with better outcomes than Azitro in treatment of COVID-19 associated pneumonia

Next Post

#VisualAbstract: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic

RelatedReports

Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Unvaccinated status increases risk of long COVID symptoms

January 25, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

December 27, 2022
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Cardiology

Slight increase of incidence of myocarditis post-mRNA SARS-CoV-2 vaccination

December 15, 2022
Next Post
#VisualAbstract: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic

#VisualAbstract: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic

Non-invasive prenatal testing linked to decreased diagnostic testing

RNA-Binding Protein RBFOX1 May Be Locus for Alzheimer’s Disease Pathogenesis

Few older adolescents meet recommended levels of physical activity

2 Minute Medicine Rewind June 29, 2020

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options